
Thomas Meier, PhD
Founder, Chairman of the Board and the Scientific Committee, Member of the Compensation & Audit Committees
Read moreWe are focusing on the development of treatments for neuromuscular and pulmonary diseases that currently lack treatment options, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF).
We have dedicated more than a decade to researching potential treatments in our ongoing mission to make effective medicines available for these often overlooked, life-altering diseases. We are passionate about improving patients’ quality of life and our vision is to be a leader in providing treatments for rare diseases in these areas with high unmet medical needs.
Founder, Chairman of the Board and the Scientific Committee, Member of the Compensation & Audit Committees
Read moreBoard Member and Chairman of the Audit Committee
Read moreBoard Member, Chairman of the Compensation Committee and Member of the Scientific Committee
Read moreChief Executive Officer
Read moreChief Financial Officer
Read morePresident North America
Read moreChief Medical Officer
Read moreHead Business Development, EVP
Read moreGeneral Counsel & Secretary to the Board, EVP
Read moreHead of People & Culture
Read moreHead Investor Relations & Communications
Read moreHead Global Marketing & Partner Management
Read moreChief of Staff
Read moreHead of Development
Read moreHead Technical Development & Operations
Read moreHead European Affiliates & EU Market Access
Read more